Pharma Pulse 7/15/24: Merck Finalizes EyeBio Purchase, Companies Sharply Criticize Draft US Cyber Reporting Rules & more

Merck Finalizes EyeBio Purchase

The acquisition in the ophthalmology space features a $1.3 billon cash payment, with the potential for an additional $1.7 billion if various milestones are met.

FDA Issues CRL for Once-Weekly Insulin for Type 1 Diabetes

FDA has issued a complete response letter for Novo Nordisk’s biologics license application for the once-weekly basal insulin icodec to treat patients with diabetes. The FDA is asking for information about the manufacturing process, as well as the type 1 diabetes indication.

Companies Sharply Criticize Draft U.S. Cyber Reporting Rules

Critical infrastructure operators say the proposed regulation is confusing and burdensome.

IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group

IQVIA™ announced that Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024 survey, which measures both market impact and delivery effectiveness.

Spencer Gore on LinkedIn

It's great to be featured in Pharmaceutical Executive discussing "How Leaders Can Empower Their People to be Their Best."

As I mention at the start of the article, the journey to excellence begins with self-belief. "If you think you can, you possibly will. If you think you can’t, you definitely won’t."

Read the full article here:https://lnkd.in/eRCki5wA

Find out more about American Medial Journal,AMJ, here: https://lnkd.in/eZkeYnir

#Pharma #Pharmaceuticals #Leadership #Healthcare #USA

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs